NSRX compared with XAIR: revenue, margins and what each company keeps, and the suppliers and customers both name

NSRXNasus Pharma Ltd

Mkt capRevenueRevenue

XAIRBeyond Air, Inc.

Mkt capRevenueRevenue

Compare

NSRXNasus Pharma Ltd

XAIRBeyond Air, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

NSRX, solidXAIR, dashed

Supply-chain overlap

Revenue flow

NSRX: latest quarter not drawable. XAIR: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NSRX 2

—Aptarunlistedsupplier

—Formulexunlistedsupplier

Shared 0

No shared counterparties.

Only XAIR 4

PLXSPlexussupplier

—Medisize Irelandunlistedsupplier

—NitricGenunlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Spartronics

unlistedsupplier

NSRXNasus Pharma Ltd

3.20▲+0.31%· post 3.20

Mkt cap$24.6MRevenue—Revenue—

XAIRBeyond Air, Inc.

2.36▲+2.16%· post 2.36

ClosedOct 30 '26

Mkt cap$2.1MRevenue$2MQ1 FY27Revenue$8MFY26

Compare

ClosedOct 30 '26

NSRXNasus Pharma Ltd

XAIRBeyond Air, Inc.

3.20▲+0.31%post 3.20

Price

2.36▲+2.16%post 2.36

$24.6M

Mkt cap

$2.1M

—

Revenue

$2MQ1 FY27

—

Revenue

$8MFY26

NSRX3.20▲+0.31%vsXAIR2.36▲+2.16%ClosedOct 30 '26